Wrapping up Q3 earnings, we look at the numbers and key takeaways for the household products stocks, including Kimberly-Clark (NASDAQ:KMB) and its peers. Household products stocks are generally stable ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...
Jan 27 (Reuters) - Kimberly-Clark exceeded quarterly profit expectations on Tuesday, helped by cost controls and steady ...
DALLAS and SUMMIT, N.J., Nov. 3, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB), a global personal care leader, and Kenvue Inc. (NYSE: KVUE), a global consumer health leader, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results